Iceland· IS-EU/1/23/1783/001
Qalsody
A tofersen product containing tofersenum inn, registered in Iceland by Biogen Netherlands B.V.. The same ATC class is registered in 11 of our 19 countries.
Checked against Icelandic Medicines Agency (Iceland) on
Informational only — not a medical device.
Where it is registered
Tofersen is registered in 11 of 19 countries.
Countries holding a registration under ATC N07XX22 (tofersen), each read from that country’s own register.
- This record: Iceland, from Icelandic Medicines Agency (Iceland)
- 7 of them publish a price we can compare per daily dose
Tofersen · ATC N07XX22
11 / 19 countries
- Belgiumprice
- Czechiaprice
- Denmark
- Finlandprice
- Icelandprice
- Ireland
- Netherlands
- Polandprice
- Switzerlandprice
- United Kingdom
- United Statesprice
The record
At a glance
Icelandic Medicines Agency (Iceland)- Active substance
- Tofersenum INN
- Manufacturer
- Biogen Netherlands B.V.
- Country
- Iceland (IS)
- ATC code
- N07XX22
- ATC class
- Tofersen
- Defined daily dose
- 3.57 mg, P
- Reimbursed
- Not published by this register
- Source register
- Icelandic Medicines Agency (Iceland)
- Last checked
- September 29, 2026
Packs & prices · 1
1 priced- ean0357701 stk x1 hglISK 3554369
Regulatory notes
No shortage, Orange Book or US label notes for this record.
Same medicine, other countries
Tofersen in 11 other countries
What each register calls a product with the same active substance — salts and hydrates count as the same.
- BelgiumQalsody 100 mgBiogen Netherlands
- CzechiaQALSODYBiogen Netherlands B.V., Badhoevedorp
- SpainQALSODY 100 MG SOLUCIÓN INYECTABLEBiogen Netherlands B.V.
- FinlandQalsodyBiogen Netherlands B.V.
- IrelandQalsody 100 mg solution for injectionBiogen Netherlands B.V.
- NetherlandsQalsody 100 mg oplossing voor injectieBiogen Netherlands B.V.
- PolandQalsody 100 mg roztwór do wstrzykiwańBiogen Netherlands B.V.
- SwedenQalsody 100 mg Injektionsvätska, lösningBiogen Netherlands B.V.
Authorised across Europe · EMA
The same active substance is authorised in 2 EEA countries. Names it is sold under:
- Liechtenstein · Qalsody
- Norway · Qalsody
Source: European Medicines Agency, Article 57 product data.
Sourced from a public register and reproduced with attribution. Drug Database is not affiliated with, endorsed by, or a partner of Icelandic Medicines Agency (Iceland). This is an informational data service and not a medical device — verify against the official source of record before any clinical decision.
For developers
The same record over the API, and the raw payload
GET /v1/drugs/086bd4a6-7580-4afa-981a-f68255b20890 GET /v1/drugs/086bd4a6-7580-4afa-981a-f68255b20890?format=fhir
Every response carries last_synced_at, so freshness is a field rather than a promise. Below is exactly what the ingestion wrote, before any presentation — the same JSON the API returns under payload.
{
"form": "Stungulyf, lausn",
"source": "lyfjastofnun",
"atc_raw": "N07XX22",
"marketed": true,
"strength": "100 mg",
"ma_number": "EU/1/23/1783/001",
"substance": "Tofersenum INN",
"other_info": null,
"legal_status": "(R) Lyfseðilsskylt\r\n(H) Sjúkrahúsmerkt",
"ma_issued_serial": "45441"
}See everything about tofersen.
This page is the registration. A free account adds the label text as the regulator wrote it, what it costs per daily dose across the markets that publish a price, a feed of what changes in the registers, and an assistant that answers with its sources. Interaction severity is free; mechanism and management are on the Growth plan. No card, nothing to install.